Verition Fund Management
SRGA

Verition Fund Management’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Verition Fund Management’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-15,318
Closed -$2.8K – 2831
2023
Q2 		$2.8K Sell
15,318
-39,487
-72% -$37.9K ﹤0.01% 2139
2023
Q1 		$87.7K Buy
54,805
+39,487
+258% +$80.3K ﹤0.01% 1921
2022
Q4 		$30K Hold
15,318
– – ﹤0.01% 1913
2022
Q3 		$53K Hold
15,318
– – ﹤0.01% 2692
2022
Q2 		$52K Sell
15,318
-1
-0% -$6 ﹤0.01% 2143
2022
Q1 		$140K Buy
15,319
+10,356
+209% +$157K ﹤0.01% 2401
2021
Q4 		$107K Hold
4,963
– – ﹤0.01% 2328
2021
Q3 		$162K Sell
4,963
-2,663
-35% -$97.5K ﹤0.01% 1644
2021
Q2 		$318K Buy
7,626
+2,470
+48% +$126K ﹤0.01% 1314
2021
Q1 		$337K Sell
5,156
-293
-5% -$20.4K ﹤0.01% 1059
2020
Q4 		$358K Sell
5,449
-1,630
-23% -$106K ﹤0.01% 771
2020
Q3 		$384K Buy
7,079
+5,472
+341% +$419K 0.01% 690
2020
Q2 		$153K Hold
1,607
– – 0.01% 981
2020
Q1 		$82K Buy
+1,607
New +$168K ﹤0.01% 531

Other funds holding SRGA

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
WWP
WR Wealth Planners Columbia, Missouri $311M AUM 18.22% 1-Year Est. Return

Verition Fund Management's SRGA Position: Q3 2023 in Review

Verition Fund Management sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q3 2023, closing a stake of 15,318 shares — an estimated $2.8K sold.

Verition Fund Management first reported a position in SRGA in Q1 2020 and held it in 14 quarters. The position peaked at $384K in Q3 2020. 4 funds tracked by Wall St. Rank hold SRGA as of Q3 2023.

  • Verition Fund Management reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Verition Fund Management sold 15,318 Surgalign Holdings, Inc. Common Stock shares in Q3 2023, an estimated $2.8K.
  • Verition Fund Management first reported a position in Surgalign Holdings, Inc. Common Stock in Q1 2020 and held it in 14 quarters.
  • Verition Fund Management's Surgalign Holdings, Inc. Common Stock position peaked at $384K in Q3 2020.
  • 4 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2023.

Based on Verition Fund Management's 13F filing for Q3 2023, filed 14 Nov 2023.